Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Elan enters $1 billion royalty deal with Theravance over potential respiratory drug sales
Elan enters $1 billion royalty deal with Theravance over potential respiratory drug sales
Elan enters $1 billion royalty deal with Theravance over potential respiratory drug sales
Submitted by
admin
on May 13, 2013 - 9:36am
Source:
Yahoo/AP
News Tags:
Elan
Theravance
GSK
Anoro Ellipta
Breo Ellipta
Headline:
Elan enters $1 billion royalty deal with Theravance over potential respiratory drug sales
Do Not Allow Advertisers to Use My Personal information
